Custom Search

News

Saturday 01 January 2000

THYMUS AND LYMPH NODE CELL CD4(+)AND CD8(+)MARKER EXPRESSION AND THEIR ANGIOGENIC ACTIVITY OF OFFSPRING OF SALBUTAMOL-TREATED PREGNANT C3H MICE.

By: Kaminski P, Skopinska-Rozewska E, Wasik M, Bany J, Barcz E, Sommer E, Marianowski L.

Pharmacol Res 2000 Jan;41(1):93-97

Salbutamol, beta(2)-adrenoceptor agonist is a first choice drug in preterm delivery treatment. The aim of the present study was to determine whether salbutamol can cause any alterations in neonatal immune systems and therefore should be considered in newborn care. The experiments were performed on 4-5- and 6-7-week-old female and male offspring of salbutamol-treated C3H inbred mice. Thymus and lymph node weight, cellularity and lymphatic organs, lymphocytes phenotypes and their angiogenic activity were evaluated. We observed lower thymus weight in 6-7-week-old progeny of salbutamol-treated mothers and in the same time lower thymus cell number in both age groups. Lower lymph node weight was developed in older progeny while cellularity was diminished both in 4-5- and 6-7-week-old offspring of salbutamol-treated mothers. We have not detected any changes in percentage of CD4, CD8, CD3 and CD4CD8 positive lymphocytes in progeny of salbutamol-treated mothers. As far as lymph node lymphocytes phenotype is considered we showed in both age groups lowering of CD4 and CD3 positive cells in experimental groups. In the LIA test (lymphocyte-induced angiogenesis) we showed lower lymph node cell angiogenic activity of salbutamol-treated mothers' progeny in both age groups. In the case of thymus lymphocytes we have not observed any alterations in their angiogenic activity. The differences in histological examination of thymus and lymph nodes were not detected in experimental and control groups. 2000 Academic Press@p$hr Copyright 2000 Academic Press.

Use of this site is subject to the following terms of use